02:24:54 EDT Sun 16 May 2021
Enter Symbol
or Name

Login ID:
Canntrust Holdings Inc
Symbol TRST
Shares Issued 141,222,547
Close 2019-07-05 C$ 6.46
Recent Sedar Documents

Canntrust greenhouse not compliant with regulations

2019-07-08 08:01 ET - News Release

Mr. Peter Aceto reports


Canntrust Holdings Inc. has received a compliance report from Health Canada notifying the company that its greenhouse facility in Pelham, Ont., is non-compliant with certain regulations. Canntrust has accepted Health Canada's non-compliance finding and has taken actions to ensure current and future compliance.

The non-compliant rating is based on observations by the regulator regarding the growing of cannabis in five unlicensed rooms and inaccurate information provided to the regulator by Canntrust employees. Growing in unlicensed rooms took place from October, 2018, to March, 2019, during which time Canntrust had pending applications for these rooms with Health Canada. These rooms were constructed in accordance with regulations and good production practices, and licences were issued for each of the five rooms in April, 2019. There are 12 rooms in total at the facility.

Health Canada has placed a hold on inventory which includes approximately 5,200 kilograms of dried cannabis that was harvested in the previously unlicensed rooms in Pelham, until it deems that the company is compliant with regulations. In addition, Canntrust has instituted a voluntary hold of approximately 7,500 kg of dried cannabis equivalent at its Vaughan manufacturing facility that was produced in the previously unlicensed rooms.

Canntrust's operations at its Pelham and Vaughan facilities remain fully licensed and the company continues to grow, cultivate, harvest and sell cannabis. Health Canada is conducting quality checks of product samples on hold at Pelham, with results expected in 10 to 12 business days. Due to the product on hold, some Canntrust customers and patients will experience temporary product shortages. The company is exploring options to mitigate these shortages.

All product sold from the impacted rooms has passed quality control testing at Health Canada certified labs as well as Canntrust's own quality control processes and safety reviews.

"Our team has focused on building a culture of transparency, trust and excellence in every aspect of our business, including our interactions with the regulator. We have made many changes to make this right with Health Canada. We made errors in judgment, but the lessons we have learned here will serve us well moving forward," said Peter Aceto, chief executive officer.

Corrective actions and additions to the Canntrust executive team

Canntrust has implemented a number of corrective actions including:

  • Further comprehensive employee training;
  • Retained external advisers for an independent review of compliance processes;
  • Comprehensive review and update of processes and procedures;
  • Voluntarily advised Health Canada of issues that may impact compliance at its Vaughan facility regarding product storage;
  • Improving the quality and compliance function at the company has been a priority for senior leadership. The first executive addition under the new leadership team was Andrea Kirk, for the newly created role of vice-president, quality. Ms. Kirk brings nearly 20 years of quality and compliance experience from the pharmaceutical industry to Canntrust and her mandate is to lead the quality and compliance department. Since joining the company in March, 2019, she has hired and trained 17 quality and compliance professionals.

Financial outlook

At this time, the impact of these matters on Canntrust's financial results are unknown until Health Canada completes its quality testing of product from Pelham which is currently on hold. Further updates will be provided as they become available.

About Canntrust Holdings Inc.

Canntrust is a federally regulated licensed producer of medical and recreational cannabis in Canada. Founded by pharmacists, Canntrust brings more than 40 years of pharmaceutical and health care experience to the medical cannabis industry and serves more than 72,000 medical patients with its dried, extract and capsule products. The company operates its Niagara perpetual harvest facility in Pelham, Ont., and prepares and packages its product portfolio at its manufacturing centre of excellence in Vaughan, Ont. The company has also purchased 81 acres of land in British Columbia and expects to secure over 240 acres of land in total for low-cost outdoor cultivation which it will use for its extraction-based products.

We seek Safe Harbor.

© 2021 Canjex Publishing Ltd. All rights reserved.